MEFENAMIC ACID (mefenamic acid) by Molecular Devices is cyclooxygenase inhibitors [moa]. Approved for mild to moderate pain in adults, older, therapy will not exceed one week (7 days) and 1 more indications. First approved in 2013.
Drug data last refreshed 20h ago
Cyclooxygenase Inhibitors
Worked on MEFENAMIC ACID at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults
Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects
Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea